Amiya K. Banerjee

Amiya K. Banerjee's AcademicInfluence.com Rankings

Amiya K. Banerjee

Biology

#9872

World Rank

#13129

Historical Rank

Developmental Biology

#123

World Rank

#131

Historical Rank

Virology

#232

World Rank

#239

Historical Rank

Molecular Biology

#1381

World Rank

#1408

Historical Rank

biology Degrees

Download Badge

Biology

Amiya K. Banerjee's Degrees

PhD Biochemistry University of California, Berkeley
Bachelors Chemistry University of Calcutta

Why Is Amiya K. Banerjee Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Amiya K. Banerjee's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Sequential transcription of the genes of vesicular stomatitis virus. (1976) (317)
Transcription and Replication of Rhabdoviruses (1987) (280)
The 5′ terminal structure of the methylated mRNA synthesized in vitro by vesicular stomatitis virus (1975) (212)
Methylation-dependent translation of viral messenger RNAs in vitro. (1975) (205)
Unconventional mechanism of mRNA capping by the RNA-dependent RNA polymerase of vesicular stomatitis virus. (2007) (200)
Two RNA polymerase complexes from vesicular stomatitis virus-infected cells that carry out transcription and replication of genome RNA. (2004) (162)
Complex formation with vesicular stomatitis virus phosphoprotein NS prevents binding of nucleocapsid protein N to nonspecific RNA (1988) (140)
A unique RNA species involved in initiation of vesicular stomatitis virus RNA transcription in vitro (1976) (140)
Phosphorylation by cellular casein kinase II is essential for transcriptional activity of vesicular stomatitis virus phosphoprotein P. (1992) (139)
Transcription In Vitro by Reovirus-Associated Ribonucleic Acid-Dependent Polymerase (1970) (137)
Transcriptional activity and mutational analysis of recombinant vesicular stomatitis virus RNA polymerase (1993) (135)
Phosphoprotein of human parainfluenza virus type 3 blocks autophagosome-lysosome fusion to increase virus production. (2014) (125)
Proteolytic Cleavage of the p65-RelA Subunit of NF-κB during Poliovirus Infection* (2005) (116)
Sequential phosphorylation of the phosphoprotein of vesicular stomatitis virus by cellular and viral protein kinases is essential for transcription activation (1992) (115)
Specific Interaction in Vitro and in Vivo of Glyceraldehyde-3-phosphate Dehydrogenase and LA Protein with Cis-acting RNAs of Human Parainfluenza Virus Type 3* (1996) (115)
Complete nucleotide sequence of the leader rna synthesized in vitro by vesicular stomatitis virus (1978) (112)
Phospholipid Scramblase 1 Potentiates the Antiviral Activity of Interferon (2004) (108)
An infectious clone of human parainfluenza virus type 3 (1997) (107)
Requirement for cyclophilin A for the replication of vesicular stomatitis virus New Jersey serotype. (2003) (103)
Phosphorylation within the amino-terminal acidic domain I of the phosphoprotein of vesicular stomatitis virus is required for transcription but not for replication (1997) (102)
Mapping of interacting domains between the nucleocapsid protein and the phosphoprotein of vesicular stomatitis virus by using a two-hybrid system. (1993) (98)
Methylated and blocked 5′ termini in vesicular stomatitis virus in vivo mRNAs (1975) (98)
Requirements and functions of vesicular stomatitis virus L and NS proteins in the transcription process in vitro. (1985) (98)
Studies on the in vitro adenylation of RNA by vesicular stomatitis virus. (1974) (97)
Novel initiation of RNA synthesis in vitro by vesicular stomatitis virus (1975) (95)
RNA polymerase of vesicular stomatitis virus specifically associates with translation elongation factor-1 αβγ for its activity (1998) (94)
Phosphorylation within a specific domain of the phosphoprotein of vesicular stomatitis virus regulates transcription in vitro (1987) (94)
The Phosphoprotein of Rabies Virus Is Phosphorylated by a Unique Cellular Protein Kinase and Specific Isomers of Protein Kinase C (2000) (93)
Inhibition of human parainfluenza virus-3 replication by interferon and human MxA. (1996) (93)
Influence of 5'-terminal m7G and 2'--O-methylated residues on messenger ribonucleic acid binding to ribosomes. (1976) (89)
RNA editing in the phosphoprotein gene of the human parainfluenza virus type 3 (1992) (85)
Two methyltransferase activities in the purified virions of vesicular stomatitis virus (1977) (84)
Small-molecule activators of RNase L with broad-spectrum antiviral activity (2007) (84)
In vitro phosphorylation of NS protein by the L protein of vesicular stomatitis virus. (1985) (82)
Histidine-mediated RNA transfer to GDP for unique mRNA capping by vesicular stomatitis virus RNA polymerase (2010) (80)
Role of Nucleolin in Human Parainfluenza Virus Type 3 Infection of Human Lung Epithelial Cells (2004) (78)
Messenger RNA species synthesized in vitro by the virion-associated RNA polymerase of vesicular stomatitis virus (1975) (77)
In vitro synthesis of methylated messenger RNA by the virion-associated RNA polymerase of vesicular stomatitis virus. (1974) (75)
Resolution of multiple complexes of phosphoprotein NS with nucleocapsid protein N of vesicular stomatitis virus (1988) (74)
Temporal activation of NF-κB regulates an interferon-independent innate antiviral response against cytoplasmic RNA viruses (2003) (74)
Involvement of cellular casein kinase II in the phosphorylation of measles virus P protein: identification of phosphorylation sites. (1995) (73)
Human parainfluenza virus type 3 transcription in vitro: role of cellular actin in mRNA synthesis (1991) (73)
The transcription complex of vesicular stomatitis virus (1987) (72)
In vitro synthesis of RNA that contains polyadenylate by virion-associated RNA polymerase of vesicular stomatitis virus. (1973) (72)
Phosphorylation of specific serine residues within the acidic domain of the phosphoprotein of vesicular stomatitis virus regulates transcription in vitro (1992) (70)
Vesicular stomatitis virus NS proteins: structural similarity without extensive sequence homology (1985) (69)
Impaired nitric oxide synthase-2 signaling pathway in cystic fibrosis airway epithelium. (2004) (68)
Interaction of Vesicular Stomatitis Virus P and N Proteins: Identification of Two Overlapping Domains at the N Terminus of P That Are Involved in N0-P Complex Formation and Encapsidation of Viral Genome RNA (2007) (67)
Cloning and expression of the vesicular stomatitis virus phosphoprotein gene in Escherichia coli: analysis of phosphorylation status versus transcriptional activity (1991) (66)
Involvement of Actin Microfilaments in the Replication of Human Parainfluenza Virus Type 3 (1998) (66)
Cellular protein kinase C isoform zeta regulates human parainfluenza virus type 3 replication. (1995) (66)
Identification of a domain within the phosphoprotein of vesicular stomatitis virus that is essential for transcription in vitro. (1986) (65)
Translation and identification of the mRNA species synthesized in vitro by the virion-associated RNA polymerase of vesicular stomatitis virus. (1975) (64)
Purified matrix protein of vesicular stomatitis virus blocks viral transcription in vitro. (1982) (62)
Polarity of Human Parainfluenza Virus Type 3 Infection in Polarized Human Lung Epithelial A549 Cells: Role of Microfilament and Microtubule (2001) (61)
Specific interactions of vesicular stomatitis virus L and NS proteins with heterologous genome ribonucleoprotein template lead to mRNA synthesis in vitro (1984) (61)
Precise mapping of the replication and transcription promoters of human parainfluenza virus type 3. (2000) (61)
Borna Disease Virus P-protein Is Phosphorylated by Protein Kinase Cε and Casein Kinase II* (1997) (61)
Messenger RNA encoding the phosphoprotein (P) gene of human parainfluenza virus 3 is bicistronic. (1986) (59)
Mapping and initiation studies on the leader RNA of vesicular stomatitis virus. (1977) (56)
Role of Cellular Casein Kinase II in the Function of the Phosphoprotein (P) Subunit of RNA Polymerase of Vesicular Stomatitis Virus (*) (1995) (56)
5′-Terminal Sequence of Vesicular Stomatitis Virus mRNA's Synthesized In Vitro (1976) (55)
Role of cellular actin in human parainfluenza virus type 3 genome transcription. (1993) (55)
Inhibition of STAT 1 Phosphorylation by Human Parainfluenza Virus Type 3 C Protein (2005) (55)
In vivo methylation of vesicular stomatitis virus and its host-cell messenger RNA species. (1976) (54)
Basic amino acid residues at the carboxy-terminal eleven amino acid region of the phosphoprotein (P) are required for transcription but not for replication of vesicular stomatitis virus genome RNA. (1997) (53)
Characterization of the in vitro system for the synthesis of mRNA from human respiratory syncytial virus. (1993) (53)
Anti-malaria drug blocks proteotoxic stress response: Anti-cancer implications (2009) (52)
Translation and identification of the viral mRNA species isolated from subcellular fractions of vesicular stomatitis virus-infected cells (1975) (52)
Optimal Replication Activity of Vesicular Stomatitis Virus RNA Polymerase Requires Phosphorylation of a Residue(s) at Carboxy-Terminal Domain II of Its Accessory Subunit, Phosphoprotein P (1999) (52)
Initiation of RNA synthesis in vitro by vesicular stomatitis virus. Role of ATP. (1979) (51)
Intervening polyadenylate sequences in RNA transcripts of vesicular stomatitis virus (1978) (50)
Phosphoprotein NS of vesicular stomatitis virus: phosphorylated states and transcriptional activities of intracellular and virion forms. (1986) (50)
Role of heparan sulfate in human parainfluenza virus type 3 infection. (2002) (50)
Identification of a Novel Tripartite Complex Involved in Replication of Vesicular Stomatitis Virus Genome RNA (2003) (49)
Absence of polyadenylic acid from reovirus messenger ribonucleic acid. (1973) (49)
Sequences of Chandipura virus N and NS genes: evidence for high mutability of the NS gene within vesiculoviruses. (1987) (48)
Complete nucleotide sequence of the mRNA coding for the N protein of vesicular stomatitis virus (New Jersey serotype). (1984) (47)
Different Effect of Proteasome Inhibition on Vesicular Stomatitis Virus and Poliovirus Replication (2008) (47)
In vitro synthesis of the full-length complement of the negative-strand genome RNA of vesicular stomatitis virus. (1980) (46)
Innate immune response against nonsegmented negative strand RNA viruses. (2003) (46)
Immunological characterization of the VSV nucleocapsid (N) protein expressed by recombinant baculovirus in Spodoptera exigua larva: use in differential diagnosis between vaccinated and infected animals. (1993) (45)
Synthesis of bacteriophage Q-beta RNA. (1968) (45)
An unconventional pathway of mRNA cap formation by vesiculoviruses. (2011) (45)
Involvement of actin microfilaments in the transcription/replication of human parainfluenza virus type 3: Possible role of actin in other viruses (1999) (44)
Human Parainfluenza Virus Type 3 Up-Regulates Major Histocompatibility Complex Class I and II Expression on Respiratory Epithelial Cells: Involvement of a STAT1- and CIITA-Independent Pathway (1999) (44)
Nucleotide sequence analysis of the L gene of vesicular stomatitis virus (New Jersey serotype): identification of conserved domains in L proteins of nonsegmented negative-strand RNA viruses. (1990) (44)
Phosphorylated states of vesicular stomatitis virus P protein in vitro and in vivo. (1997) (43)
The nature of the RNA products synthesized in vitro by subviral components of visicular stomatitis virus. (1976) (43)
Expression and purification of vesicular stomatitis virus N-P complex from Escherichia coli: role in genome RNA transcription and replication in vitro (1997) (43)
Sub-cellular localization of vesicular stomatitis virus messenger RNAs. (1975) (42)
Studies on human parainfluenza virus 3: characterization of the structural proteins and in vitro synthesized proteins coded by mRNAs isolated from infected cells. (1985) (42)
Phosphorylation of Sendai Virus Phosphoprotein by Cellular Protein Kinase C ζ* (1997) (41)
NH2-terminal acidic region of the phosphoprotein of vesicular stomatitis virus can be functionally replaced by tubulin. (1988) (41)
Characterization of an in vitro system for the synthesis of mRNA from human parainfluenza virus type 3 (1990) (40)
Role of NH2- and COOH-Terminal Domains of the P Protein of Human Parainfluenza Virus Type 3 in Transcription and Replication (2000) (39)
RNA polymerase of vesicular stomatitis virus specifically associates with translation elongation factor-1 alphabetagamma for its activity. (1998) (37)
Rescue of synthetic analogs of genome RNA of human parainfluenza virus type 3. (1993) (37)
Structure and expression of the glycoprotein gene of Chandipura virus. (1989) (37)
The HR motif in the RNA-dependent RNA polymerase L protein of Chandipura virus is required for unconventional mRNA-capping activity. (2010) (36)
Guanosine-5'-diphosphate at the 5' termini of reovirus RNA: evidence for a segmented genome within the virion. (1971) (36)
Efficient interaction of the vesicular stomatitis virus P protein with the L protein or the N protein in cells expressing the recombinant proteins. (1995) (36)
Conserved structures among the nucleocapsid proteins of the paramyxoviridae: complete nucleotide sequence of human parainfluenza virus type 3 NP mRNA. (1986) (35)
Complete nucleotide sequence of the matrix protein mRNA of vesicular stomatitis virus (New Jersey serotype). (1986) (35)
Studies on the in vivo and in vitro messenger RNA species of vesicular stomatitis virus. (1975) (34)
Identification of promoter-proximal oligonucleotides and a unique dinucleotide, pppGpC, from in vitro transcription products of vesicular stomatitis virus (1981) (34)
Mapping and Functional Role of the Self-Association Domain of Vesicular Stomatitis Virus Phosphoprotein (2006) (34)
Casein kinase II is the P protein phosphorylating cellular kinase associated with the ribonucleoprotein complex of purified vesicular stomatitis virus. (1995) (32)
The functional domains of the phosphoprotein (NS) of vesicular stomatitis virus (Indiana serotype). (1988) (32)
Specific Phosphorylated Forms of Glyceraldehyde 3-Phosphate Dehydrogenase Associate with Human Parainfluenza Virus Type 3 and Inhibit Viral Transcription In Vitro (2000) (31)
Replication of RNA viruses. V. Template activity of synthetic ribopolymers in the Q-beta RNA polymerase reaction. (1967) (31)
The human parainfluenza virus type 3 (HPIV 3) C protein inhibits viral transcription. (2004) (31)
Characterization of the oligomerization domain of the phosphoprotein of human parainfluenza virus type 3. (2002) (30)
Analysis of the mutations in the active site of the RNA-dependent RNA polymerase of human parainfluenza virus type 3 (HPIV3). (2002) (30)
Formation of Guanosine(5′)Tetraphospho(5′)Adenosine Cap Structure by an Unconventional mRNA Capping Enzyme of Vesicular Stomatitis Virus (2008) (30)
Inhibition of vesicular stomatitis virus infection in epithelial cells by alpha interferon-induced soluble secreted proteins. (2006) (30)
Mechanism of selective translation of vaccinia virus mRNAs: differential role of poly(A) and initiation factors in the translation of viral and cellular mRNAs (1991) (30)
Specific Interaction of Heterogeneous Nuclear Ribonucleoprotein Particle U with the Leader RNA Sequence of Vesicular Stomatitis Virus (1998) (30)
In vitro synthesis of messenger RNA by a defective interfering particle of vesicular stomatitis virus. (1977) (29)
In vitro synthesis of RNA containing 5'-terminal structure 7nG(5')ppp(5')Apm... by purified wound tumor virus. (1977) (29)
Poly(riboadenylic acid) preferentially inhibits in vitro translation of cellular mRNAs compared with vaccinia virus mRNAs: possible role in vaccinia virus cytopathology. (1986) (29)
Phosphorylation of canine distemper virus P protein by protein kinase C-zeta and casein kinase II. (1997) (29)
Poly(A) Polymerase Activity in Reovirus (1974) (28)
Characterization of vesicular stomatitis virus mRNA species synthesized in vitro (1977) (27)
Human parainfluenza virus type 3 phosphoprotein: identification of serine 333 as the major site for PKC zeta phosphorylation. (1995) (27)
Role of a Highly Conserved NH2-Terminal Domain of the Human Parainfluenza Virus Type 3 RNA Polymerase (2002) (26)
N-Terminal Phosphorylation of Phosphoprotein of Vesicular Stomatitis Virus Is Required for Preventing Nucleoprotein from Binding to Cellular RNAs and for Functional Template Formation (2013) (26)
Reovirus-Specific Ribonucleic Acid from Polysomes of Infected L Cells (1972) (26)
Expression of L protein of vesicular stomatitis virus Indiana serotype from recombinant baculovirus in insect cells: requirement of a host factor(s) for its biological activity in vitro (1996) (26)
Two separate domains within vesicular stomatitis virus phosphoprotein support transcription when added in trans. (1987) (25)
Interaction between the Nucleocapsid Protein and the Phosphoprotein of Human Parainfluenza Virus 3. (1995) (25)
Borna disease virus P-protein is phosphorylated by protein kinase Cepsilon and casein kinase II. (1997) (25)
Nucleotide sequence of the leader RNA of the New Jersey serotype of vesicular stomatitis virus. (1978) (25)
In vitro RNA transcription by the New Jersey serotype of vesicular stomatitis virus. I. Characterization of the mRNA species (1978) (25)
E-type prostaglandins and gastric acid secretion in the rat. (1972) (24)
Human Parainfluenza Virus Type 3 Inhibits Gamma Interferon-Induced Major Histocompatibility Complex Class II Expression Directly and by Inducing Alpha/Beta Interferon (2001) (24)
Unique capping activity of the recombinant RNA polymerase (L) of vesicular stomatitis virus: association of cellular capping enzyme with the L protein. (2002) (24)
Analysis of RNA secondary structure in replication of human parainfluenza virus type 3. (2000) (23)
Inhibition of human parainfluenza virus type 3 infection by novel small molecules. (2008) (23)
Origin of Reovirus Oligo(A) (1974) (23)
Complete nucleotide sequence of the matrix protein mRNA and three intergenic junctions of human parainfluenza virus type 3. (1987) (22)
Intergenic sequences of the vesicular stomatitis virus genome (New Jersey serotype): evidence for two transcription initiation sites within the L gene. (1987) (22)
Cytosine at the 3'-termini of reovirus genome and in vitro mRNA. (1971) (21)
Carboxy-terminal five amino acids of the nucleocapsid protein of vesicular stomatitis virus are required for encapsidation and replication of genome RNA. (1999) (21)
Cloning and gene assignment of mRNAs of human parainfluenza virus 3. (1985) (20)
Initiation of reovirus mRNA synthesis in vitro. (1971) (20)
Quercetinase pirin makes poliovirus replication resistant to flavonoid quercetin. (2008) (19)
Expression of the vesicular stomatitis virus nucleocapsid protein gene in Escherichia coli: analysis of its biological activity in vitro. (1993) (19)
Nucleoside diphosphate kinase activity in purified cores of vesicular stomatitis virus. (1979) (18)
Inflammasome Antagonism by Human Parainfluenza Virus Type 3 C Protein (2017) (18)
Synthesis in vitro of the full-length complement of defective-interfering particle RNA of vesicular stomatitis virus. (1980) (17)
Selective inhibition of protein synthesis by synthetic and vaccinia virus-core synthesized poly(riboadenylic acids). (1987) (17)
Phosphoprotein, P of human parainfluenza virus type 3 prevents self-association of RNA-dependent RNA polymerase, L. (2009) (16)
Replication of RNA viruses, IV. Initiation of RNA synthesis by the q-beta RNA polymerase. (1967) (16)
Characterization of vaccinia virus transcripts involved in selective inhibition of host protein synthesis. (1986) (15)
In vitro synthesis of genome length complementary RNA of vesicular stomatitis virus in the presence of inosine 5'-triphosphate. (1983) (15)
Human parainfluenza virus type 3 upregulates ICAM-1 (CD54) expression in a cytokine-independent manner. (2001) (15)
3'-Terminal sequence of vesicular stomatitis virus genome RNA. (1976) (15)
Protamine--a potent inhibitor of vesicular stomatitis virus transcriptase in vitro. (1981) (14)
Inactivation of influenza and vesicular stomatitis virion RNA polymerase activities by photoreaction with 4'-substituted psoralens (1979) (14)
Expression of the human MxA protein is associated with hyperphosphorylation of VSV P protein in human neural Cells. (1996) (14)
In vitro transcription of wound tumor virus RNA by virion-associated RNA transcriptase. (1977) (14)
Production and characterization of a monoclonal antibody to the N protein of vesicular stomatitis virus (Indiana serotype). (1982) (13)
Role of cellular kinases in the gene expression of nonsegmented negative strand RNA viruses. (1997) (13)
Interaction of L and NS proteins of vesicular stomatitis virus with its template ribonucleoprotein during RNA synthesis in vitro. (1984) (13)
An identical 3'-terminal sequence in the ten reovirus genome RNA segments. (1971) (12)
N-terminally truncated C protein, CNDelta25, of human parainfluenza virus type 3 is a potent inhibitor of viral replication. (2009) (11)
In vitro RNA transcription by the New Jersey serotype of vesicular stomatitis virus. II. Characterization of the leader RNA (1978) (11)
Inhibition of vesicular stomatitis virus transcriptase in vitro by phosphonoformate and ara-ATP. (1980) (11)
In vitro synthesis of a possible precursor RNA by purified vesicular stomatitis virus. (1978) (11)
Ribonuclease activity is associated with subviral particles isolated from interferon-treated vesicular stomatitis virus-infected cells (1988) (10)
Microinjection of vesicular stomatitis virus ribonucleoprotein into animal cells yields infectious virus. (1983) (10)
Covalent attachment of psoralen to a single site on vesicular stomatitis virus genome RNA blocks expression of viral genes. (1982) (10)
Two distinct populations of vesicular stomatitis virus ribonucleoprotein cores with differential sensitivities to micrococcal nuclease. (1979) (10)
Analysis of the RNA species isolated from defective particles of vesicular stomatitis virus. (1976) (10)
Dependence of translation on 5'-terminal methylation of mRNA. (1976) (9)
Restricted replication of vesicular stomatitis virus in T lymphocytes is coincident with a deficiency in a cellular protein kinase required for viral transcription. (1992) (9)
Response to "Non-segmented negative-strand RNA virus RNA synthesis in vivo". (2008) (8)
In vitro Transcription of Double-Stranded RNA by Reovirus-Associated RNA Polymerase (1970) (8)
Alteration of specific amino acid residues in the acidic domain I of VSV phosphoprotein (P) converts a GAL4-P(I) hybrid into a transcriptional activator. (1991) (8)
Defective interfering particles of VSVNJ (Ogden), generated by heat treatment, contain multiple internal genomic deletions. (1986) (7)
Poly(A)-adjacent sequence of the 14.5 S mRNA of vesicular stomatitis virus (New Jersey serotype). (1980) (7)
Effect of temperature on the enzymatic activities present in purified virions of vesicular stomatitis virus. (1979) (7)
mRNA capping by vesicular stomatitis virus and other related viruses (2011) (7)
Display of disparate transcription phenotype by the phosphorylation negative P protein mutants of vesicular stomatitis virus, Indiana serotype, expressed in E. coli and eucaryotic cells. (1997) (7)
Domain within the C protein of human parainfluenza virus type 3 that regulates interferon signaling. (2010) (6)
Blocked and unblocked 5'termini in vesicular stomatitis virus product RNA in vitro: their possible role in mRNA biosynthesis. (1976) (6)
Beta-catenin associates with human parainfluenza virus type 3 ribonucleoprotein complex and activates transcription of viral genome RNA in vitro. (2004) (6)
Translation of Animal Virus mRNAs in Vitro (1977) (6)
Specific binding of guanosine 5'-diphosphate with the NS protein of vesicular stomatitis virus. (1983) (5)
Expression, purification, and characterization of rhabdovirus polymerase. (1996) (4)
Transcription of Vesicular Stomatitis Virus Genome RNA (1985) (4)
Activation of the virion-associated RNA polymerase of vesicular stomatitis virus by melittin. (1982) (4)
Purified vesicular stomatitis virus contains an enzyme activity that synthesizes cytidylyl (5'-3') guanosine 5'-triphosphate in vitro. (1981) (4)
Structural and functional properties of the vesicular stomatitis virus nucleoprotein-RNA complex as revealed by proteolytic digestion. (2010) (3)
Sequential Phosphorylation ofthePhosphoprotein ofVesicular Stomatitis Virus byCellular andViral Protein Kinases IsEssential forTranscription Activation (1992) (3)
Evidence for phosphorylation of human parainfluenza virus type 3 C protein: mutant C proteins exhibit variable inhibitory activities in vitro. (2009) (3)
Viral Defense Mechanisms against Interferon (2006) (3)
Inhibition of vesicular stomatitis virus in cells constitutively expressing an antisense RNA targeted against the virus RNA polymerase gene. (1997) (3)
Structure and function of vesicular stomatitis virus NS protein (1985) (2)
Effect of proteolytic digestion on the function of vesicular stomatitis virus ribonucleoprotein complex (1987) (2)
Borna Disease Virus P-protein Is Phosphorylated by Protein Kinase C e and Casein Kinase II * (1997) (2)
CHARACTERIZATION OF STRUCTURAL PROTEINS OF PARAINFLUENZA VIRUS 3 AND mRNAs FROM INFECTED CELLS (1984) (2)
Interferon type I downregulates human parainfluenza virus type 3-induced major histocompatibility complex class II expression. (2002) (2)
Role of human beta defensin 3 during type I interferon mediated antiviral response against vesicular stomatitis virus (2010) (2)
Borna Disease Virus P-protein Is Phosphorylated by Protein (1997) (2)
Reverse genetics of negative strand RNA viruses. (1994) (2)
Probing the structure and function of viral RNA genomes (1987) (1)
The interaction of vesicular stomatitis virus nucleocapsid protein (N) with itself and RNA is regulated by the phospho-protein (NS) (1988) (1)
Cellular protein kinase C isoform C regulates human parainfluenza virus type 3 replication ( protein phosphorylation / viral replication / RNA virus ) (2005) (1)
Chandipura, Piry and Isfahan Viruses (Rhabdoviridae) (1999) (1)
EVIDENCE FOR THE SYNTHESIS OF A ‘LEADER’ RNA SEGMENT FOLLOWED BY THE SEQUENTIAL TRANSCRIPTION OF THE GENES OF VESICULAR STOMATITIS VIRUS (1976) (1)
Frequent intragenic transcription termination within the N gene of vesicular stomatitis virus. (1982) (1)
RHABDOVIRUSES (RHABDOVIRIDAE): Ungrouped Mammalian, Bird and Fish Rhabdoviruses (1999) (1)
Anti-malaria drug blocks proteotoxic stress response: (2010) (1)
SPECIFICITY OF INTERACTION OF L, NS, AND M PROTEINS WITH N-RNA COMPLEX OF VESICULAR STOMATITIS VIRUS IN A HETEROLOGOUS IN VITRO RECONSTITUTION SYSTEM (1984) (0)
ABSTRACTS FROM THE 2010 NANOBIO COLLABORATIVE (NBC) CONFERENCE (2011) (0)
NH 2-terminal acidic region of the phosphoprotein of vesicular stomatitis virus can be functionally replaced by tubulin ( cloning in pGEM vector / transcription-translation / chimeric protein / transcription activators ) DHRUBAJYOTI CHATTOPADHYAY (0)
Vesicular stomatitis virus phosphoprotein (NS): Functional roles of discrete domains within the polypeptide (1988) (0)
Structure and Function of the Vesicular Stomatitis Virus RNA-Dependent RNA Polymerase (1993) (0)
Erratum: Casein kinase II is the P protein phosphorylating cellular kinase associated with the ribonucleoprotein complex of purified vesicular stomatitis virus (Journal of General Virology (1995) 76 (365-372)) (1995) (0)
Formationand for Functional Template Nucleoprotein from Binding to Cellular Virus Is Required for Preventing Phosphoprotein of Vesicular Stomatitis N-Terminal Phosphorylation of (2014) (0)
Replication Virus Type 3 in Transcription and of the P Protein of Human Parainfluenza-and COOH-Terminal Domains 2 Role of NH (2000) (0)
Transcription of reovirus RNA. (1974) (0)
Replication of RNA viruses. 8. Direction of chain growth in the Q-beta RNA polymerase reaction. (1969) (0)
Evidence for phosphorylation of human parainfluenza virus type 3 C protein: possible role in viral transcription (2006) (0)
Infected L Cells Acid from Polysomes of Reovirus-Specific Ribonucleic (2013) (0)
synthesis.role of cellular actin in mRNA Human parainfluenza virus type 3 transcription (2013) (0)
Novel binding of GTP to the phosphoprotein (P) of vesicular stomatitis virus. (2002) (0)
Infectious clone of human parainfluenza virus-type (1998) (0)
Aaron J. Shatkin (1934–2012) (2012) (0)
Vesicular Stomatitis Virus NS Proteins: Structural Similarity Without Extensive Sequence Homologyt (0)
Specific Interactions ofVesicular Stomatitis VirusL andNS Proteins withHeterologous GenomeRibonucleoprotein (1984) (0)
Career as a molecular virologist. (1993) (0)
virus-infected cells. interferon-treated vesicular stomatitis subviral particles isolated from Ribonuclease activity is associated with (2013) (0)
Replication of Nonsegmented Negative Strand RNA Viruses (2018) (0)
Erratum: Gene expression of nonsegmented negative strand RNA viruses (Pharmacology and Therapeutics, Vol. 51(1): 47-70 (1991)) (1991) (0)
Phosphorylation ofSpecific Serine Residues within theAcidic DomainofthePhosphoprotein ofVesicular Stomatitis VirusRegulates Transcription InVitro (1992) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Amiya K. Banerjee?

Amiya K. Banerjee is affiliated with the following schools:

Leiden University

Amiya K. Banerjee's Academic­Influence.com Rankings

Amiya K. Banerjee's Degrees

Why Is Amiya K. Banerjee Influential?

Amiya K. Banerjee's Published Works

Published Works

What Schools Are Affiliated With Amiya K. Banerjee?

Amiya K. Banerjee's AcademicInfluence.com Rankings